RecoveryResearch Phase

Matrikine Peptides

Topical, Subcutaneous injection

Overview

Matrikine peptides are bioactive fragments released from extracellular matrix proteins during tissue remodeling or injury. These sequences, derived from collagen, elastin, fibronectin, and laminin, regulate cellular processes including migration, proliferation, and differentiation by binding to cell surface receptors.

Mechanism of Action

Matrikines serve as endogenous signals coordinating wound healing and tissue homeostasis..

Research Summary & Key Findings

Preclinical research has identified multiple matrikine sequences with distinct activities, such as the elastin-derived VGVAPG hexapeptide promoting chemotaxis and the collagen-derived DGEA sequence supporting cell adhesion. In vitro and animal models have demonstrated roles in angiogenesis, inflammation resolution, and matrix synthesis. Clinical translation has been limited to topical cosmetic applications, with no approved pharmaceutical indications.

Clinical Status

Research Phase

Matrikine Peptides is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

TopicalSubcutaneous injection

Related Peptides in Recovery

Find a Provider

Find a verified provider who offers Matrikine Peptides therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Matrikine Peptides.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.